Use of Indomethacin for mild and moderate Covid -19 patients A Randomized Control Trial
Rajan Ravichandran, Surapaneni Krishna Mohan, Suresh Kumar Sukumaran, Devakumar Kamaraj, Sumetha Suga Daivasuga, Samson Oliver Abraham Samuel Ravi, Sivakumar Vijayaraghavalu, Ramarathnam Krishna Kumar
doi: https://doi.org/10.1101/2021.07.24.21261007
Rajan Ravichandran
1Department of Nephrology, MIOT International, Chennai 600089, India and Adjunct Faculty, Indian Institute of Technology Madras (IITM), Chennai 600036, Tamil Nadu (TN), India
Surapaneni Krishna Mohan
2Departments of Biochemistry, Molecular Virology & Research, Panimalar Medical College Hospital & Research Institute, Chennai 600123, TN, India
Suresh Kumar Sukumaran
3Department of General Medicine, Panimalar Medical College Hospital & Research Institute, Chennai 600123, TN, India
Devakumar Kamaraj
4Departments of Pharmacology & Research, Panimalar Medical College Hospital & Research Institute, Chennai 600123, TN, India
Sumetha Suga Daivasuga
5Departments of Microbiology & Molecular Virology, Panimalar Medical College Hospital & Research Institute, Chennai 600123, TN, India
Samson Oliver Abraham Samuel Ravi
6Molbio Diagnostics Private Limited, Verna Industrial Estate, Verna, Goa - 403 722, India
Sivakumar Vijayaraghavalu
7Narayana Translational Research and Incubation Center, Narayana Medical College, Nellore 524003, Andhra Pradesh, India and Adjunct Faculty, IITM, Chennai 600036, TN, India
Ramarathnam Krishna Kumar
8Department of Engineering Design, IITM, Chennai 600036, TN, India
Data Availability
All data are available and can be obtained with ethics committee clearance
Posted July 25, 2021.
Use of Indomethacin for mild and moderate Covid -19 patients A Randomized Control Trial
Rajan Ravichandran, Surapaneni Krishna Mohan, Suresh Kumar Sukumaran, Devakumar Kamaraj, Sumetha Suga Daivasuga, Samson Oliver Abraham Samuel Ravi, Sivakumar Vijayaraghavalu, Ramarathnam Krishna Kumar
medRxiv 2021.07.24.21261007; doi: https://doi.org/10.1101/2021.07.24.21261007
Use of Indomethacin for mild and moderate Covid -19 patients A Randomized Control Trial
Rajan Ravichandran, Surapaneni Krishna Mohan, Suresh Kumar Sukumaran, Devakumar Kamaraj, Sumetha Suga Daivasuga, Samson Oliver Abraham Samuel Ravi, Sivakumar Vijayaraghavalu, Ramarathnam Krishna Kumar
medRxiv 2021.07.24.21261007; doi: https://doi.org/10.1101/2021.07.24.21261007
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)